Improvement of the Lipid Profile with Zofenopril in Hypertensive Patients with the Metabolic Syndrome
The Open Clinical Chemistry Journal · 2008
DOI: 10.2174/1874241600801010064 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open Clinical Chemistry Journal, 2008. Verfasst von Evangelos C. Rizos und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
The effect of the anti-hypertensive drug zofenopril on metabolic parameters in patients with the metabolic syndrome (MetS) is currently unknown.The present study was conducted in order to evaluate whether zofenopril affects parameters involved in the atherosclerotic process.This open-label intervention study included 60 adult patients with essential hypertension that additionally had 2 or more of the following MetS criteria: waist circumference > 102 cm in men and > 88 cm in women, triglycerides > 150 mg/dl, high density lipoprotein cholesterol (HDL-C) < 40 mg/dl in men and < 50 mg/dl in women, and fasting glucose 100 mg/dl.Zofenopril reduced systolic blood pressure by 11% (p
Zitieren
APA
Rizos, E. C., Tsouli, S., Doumas, M., Kostapanos, M., Lagos, K., Tselepis, A. D., & Elisaf, M. (2008). Improvement of the Lipid Profile with Zofenopril in Hypertensive Patients with the Metabolic Syndrome. The Open Clinical Chemistry Journal. https://doi.org/10.2174/1874241600801010064
Vancouver
Rizos EC, Tsouli S, Doumas M, Kostapanos M, Lagos K, Tselepis AD, et al. Improvement of the Lipid Profile with Zofenopril in Hypertensive Patients with the Metabolic Syndrome. The Open Clinical Chemistry Journal. 2008. doi:10.2174/1874241600801010064
BibTeX
@article{Rizos2008,
author = {Rizos, Evangelos C. and Tsouli, Sofia and Doumas, Michalis and Kostapanos, Michael and Lagos, Konstantinos and Tselepis, Alexandros D. and Elisaf, Moses},
title = {Improvement of the Lipid Profile with Zofenopril in Hypertensive Patients with the Metabolic Syndrome},
journal = {The Open Clinical Chemistry Journal},
year = {2008},
doi = {10.2174/1874241600801010064}
}
EUVIMED